Abiopharma

🔍 Scherf-Siboni Sivan (Executive)

Company: Foresight Autonomous Holdings Ltd. (FRSX)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Acquired 4,000,000 shares of Ordinary Shares (Direct)
  Date: 2026-08-13 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,257,143.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 150,000.00 | Footnotes: F2, F3

Footnotes:

• F1: Includes 4,000,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029. Each RSU represents the right to receive one Ordinary Share.
• F2: The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
• F3: The securities are owned by Moshe Scherf, Mrs. Siboni Scherf's spouse, and, therefore, Mrs. Siboni Scherf may be deemed to beneficially own securities owned by Mr. Scherf, to the extent of her spouse's pecuniary interest therein. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.